Abstract
New ELISA assays were developed to measure immunoreactivity for XMRV. Antibody titers were measured in a cohort of prostate cancer cases and cancer free controls from the central United States. No statistically significant differences were observed in immunoreactivity between cases and controls for either the XMRV-env or the XMRV-gag antigen.
Original language | English (US) |
---|---|
Pages (from-to) | 134-136 |
Number of pages | 3 |
Journal | Molecular and Cellular Probes |
Volume | 25 |
Issue number | 2-3 |
DOIs | |
State | Published - Apr 2011 |
Keywords
- ELISA
- Epidemiology
- Prostate cancer
- Virus
- XMRV
- Xenotropic murine leukemia Virus-related virus
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology